Subscribe to RSS
DOI: 10.1055/s-0033-1358910
“Still crazy after all these years” – Tuberculosis as an Old Disease with Diverse Facets in a Thirty-five-year-old Male Patient
“Still crazy after all these years” – die „alte Dame“ Tuberkulose mit ihren verschiedenen Facetten bei einem 35-jährigen PatientenCorresponding author
Publication History
received15 October 2013
accepted22 October 2013
Publication Date:
03 December 2013 (online)
Abstract
We report about a thirty-five-year-old male patient with miliary TB as first manifestation of HIV-infection.
#
Zusammenfassung
Wir berichten über einen 35-jährigen Patienten mit Miliartuberkulose als Erstmanifestation einer HIV-Infektion.
#
The Case
A thirty-five-year-old black male patient (BMI 21.1 kg/m2) was transferred to our hospital for further treatment of miliary tuberculosis (TB) which had been diagnosed elsewhere. Besides hepatomegalia due to confirmed tuberculotic affection, a CT scan showed enlarged mediastinal and abdominal lymph nodes with features of central necrosis and multiple disseminated pulmonary and splenic lesions ([Fig. 1 – 3]). HIV testing was positive, most likely as a consequence of unsafe sexual contacts with changing partners during a long-term stay in his home-country Kenya. Therefore, due to 1) HIV infection, 2) tuberculosis as acquired immune deficiency syndrome (AIDS)-defining disease and 3) a CD4-cell count of 30 per µl AIDS in CDC category C3 was diagnosed [1]. Standard antituberculotic treatment consisting of isoniazide (H), rifampicine (R), ethambutole (E) and pyrazinamide (Z) [2] had been paused at the time of admission to our hospital due to elevation of liver enzymes. Consequently, first sputum samples obtained in our hospital showed smear-positive pulmonary TB. Later on, the cultural result showed Mycobacterium tuberculosis (MTB) multisensitive to the antituberculotic medication mentioned above. We restarted treatment with E and replaced R, Z and H by levofloxacin (LFX), streptomycin (SM) and rifabutin (RFB). As to lymph node enlargement, lymphoma as well as Pneumocystis jiroveci (PCJ)-pneumonia as additional AIDS-defining diseases was excluded. Meanwhile, bone marrow samples indicated additional TB-affection ([Fig. 4]). Under treatment with SM for 30 days, LFX, RFB and E sputum samples were negative for MTB. Blood samples showed rising CD4-cell count and 1 734 015 copies of HIV-1 per ml. After patient’s transfer to a specialized department for AIDS, antituberculotic medication could be switched to RFB, E, Z and H with sustained success concerning microbiological results and stable laboratory liver parameters. Antiretroviral treatment with efavirenz, emtricitabine, and tenofovir was initiated. After four months of therapy, antituberculotic treatment could be reduced to RFB and H.








Before admission to our hospital electrolyte imbalance with severe hyponatremia had been observed. Retrospectively, they were most likely due to syndrome of inadequate antidiuretic hormone secretion (SIADH) as TB-related phenomenon [3]. However, this assumption could not be verified, since levels of electrolytes and Copeptin A, a new biomarker for SIADH [4], were normalized at time of admission to our department. Copeptin has been evaluated as prognostic biomarker in community acquired-pneumonia [5] [6], but its diagnostic value in SIADH in the context of infectious diseases might be limited to a narrow time slot.
#
Conclusion
We present a case of extended miliary TB in a black male patient with African migration background and HIV infection as sexual transmitted disease (STD) and TB favouring disease.
#
#
Conflict of Interest
The authors have no conflict of interest.
Acknowledgement
The authors would like to thank Professor Dr. Andrea Tannapfel for providing the histological figure.
-
References
- 1 Schneider E, Whitmore S, Glynn KM et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <18 years – United States, 2008. MMWR Recomm Rep 2008; 57: 1-12
- 2 Schaberg T, Bauer T, Castell S et al. Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP). Pneumologie 2012; 66: 133-171
- 3 Knoop H, Knoop U, Behr J et al. Syndrome of inadequate antidiuretic hormone secretion in pulmonary tuberculosis – a therapeutic challenge. Pneumologie 2013; 67: 219-222
- 4 Fenske W, Störk S, Blechschmidt A et al. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009; 94: 123-9
- 5 Kolditz M, Halank M, Schulte-Hubbert B et al. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med 2012; 106: 1320-1328
- 6 Kolditz M, Ewig S, Höffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 2013; 41: 974-984
Corresponding author
-
References
- 1 Schneider E, Whitmore S, Glynn KM et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <18 years – United States, 2008. MMWR Recomm Rep 2008; 57: 1-12
- 2 Schaberg T, Bauer T, Castell S et al. Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP). Pneumologie 2012; 66: 133-171
- 3 Knoop H, Knoop U, Behr J et al. Syndrome of inadequate antidiuretic hormone secretion in pulmonary tuberculosis – a therapeutic challenge. Pneumologie 2013; 67: 219-222
- 4 Fenske W, Störk S, Blechschmidt A et al. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009; 94: 123-9
- 5 Kolditz M, Halank M, Schulte-Hubbert B et al. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med 2012; 106: 1320-1328
- 6 Kolditz M, Ewig S, Höffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 2013; 41: 974-984







